Follow
Arshag Mooradian
Arshag Mooradian
Verified email at jax.ufl.edu
Title
Cited by
Cited by
Year
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
DL Bhatt, KAA Fox, W Hacke, PB Berger, B HR, …
N Engl J Med. 354, 1706-1717, 2006
36542006
A randomized trial of therapies for type 2 diabetes and coronary artery disease
BARI 2D Study Group
New England Journal of Medicine 360 (24), 2503-2515, 2009
20272009
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association
JP Bantle, J Wylie-Rosett, AL Albright, CM Apovian, NG Clark, MJ Franz, ...
Diabetes care 31, S61-S78, 2008
14842008
Biological actions of androgens
AD Mooradian, JE Morley, SG Korenman
Endocrine reviews 8 (1), 1-28, 1987
13951987
Dyslipidemia in type 2 diabetes mellitus
AD Mooradian
Nature Reviews Endocrinology 5 (3), 150-159, 2009
12542009
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association
American Diabetes Association
Diabetes care 30 (suppl_1), S48-S65, 2007
12202007
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications
MJ Franz, JP Bantle, CA Beebe, JD Brunzell, JL Chiasson, A Garg, ...
Diabetes care 25 (1), 148-198, 2002
11652002
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
BGL al for GEMINI Investigators
JAMA. 292, 2227-2236, 2004
11202004
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
BDL al for CHARISMA Investigators
J Am Coll Cardiol. 49, 1982-1988, 2007
9502007
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications
American Diabetes Association
Diabetes care 25 (suppl_1), s50-s60, 2002
9042002
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.
BE al
Diabetes Care 30, 890-895, 2007
6622007
Nutrition principles and recommendations in diabetes
American Diabetes Association
Diabetes care 27 (suppl_1), s36-s36, 2004
6592004
Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. A randomized, controlled, double-blind trial.
TMA al on behalf of Glipizide GITS Study Investigators
JAMA 280, 1490-1496, 1998
5811998
Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load
FQ Nuttall, AD Mooradian, MC Gannon, C Billington, P Krezowski
Diabetes care 7 (5), 465-470, 1984
5341984
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial.
ASC al for the rhNGF Clinical Investigator Group
JAMA 284, 2215-2221, 2000
4462000
Secondary hypogonadism in older men: its relation to impotence
SG KORENMAN, JE MORLEY, AD MOORADIAN, SS DAVIS, FE KAISER, ...
The Journal of Clinical Endocrinology & Metabolism 71 (4), 963-969, 1990
4101990
Antioxidant properties of steroids
AD Mooradian
The Journal of steroid biochemistry and molecular biology 45 (6), 509-511, 1993
3761993
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial
FG McMahon, K Fujioka, BN Singh, CM Mendel, E Rowe, K Rolston, ...
Archives of Internal Medicine 160 (14), 2185-2191, 2000
3572000
Patients with peripheral arterial disease in the CHARISMA trial.
PP Cacoub, DL Bhatt, PG Steg, EJ Topol, MA Creager, -
Eur Heart J. 30, 192-201, 2009
3552009
Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.
FK the Sibutramine/Diabetes Clinical Study Group
Diabetes, Obesity and Metabolism 2, 175-187, 2000
3432000
The system can't perform the operation now. Try again later.
Articles 1–20